These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1432625)

  • 21. Ion-pair formation as a strategy to enhance topical delivery of salicylic acid.
    Megwa SA; Cross SE; Benson HA; Roberts MS
    J Pharm Pharmacol; 2000 Aug; 52(8):919-28. PubMed ID: 11007062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffusion modeling of percutaneous absorption kinetics. 1. Effects of flow rate, receptor sampling rate, and viable epidermal resistance for a constant donor concentration.
    Anissimov YG; Roberts MS
    J Pharm Sci; 1999 Nov; 88(11):1201-9. PubMed ID: 10564070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling of diffusion with partitioning in stratum corneum using a finite element model.
    Barbero AM; Frasch HF
    Ann Biomed Eng; 2005 Sep; 33(9):1281-92. PubMed ID: 16133933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of water vapor sorption in porcine stratum corneum.
    Liron Z; Clewell HJ; McDougal JN
    J Pharm Sci; 1994 May; 83(5):692-8. PubMed ID: 8071823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin permeation of physostigmine from fatty acids-based formulations: evaluating the choice of solvent.
    Wang MY; Yang YY; Heng PW
    Int J Pharm; 2005 Feb; 290(1-2):25-36. PubMed ID: 15664127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical investigation of the topical administration of phenserine: transdermal flux, cholinesterase inhibition, and cognitive efficacy.
    Utsuki T; Uchimura N; Irikura M; Moriuchi H; Holloway HW; Yu QS; Spangler EL; Mamczarz J; Ingram DK; Irie T; Greig NH
    J Pharmacol Exp Ther; 2007 Apr; 321(1):353-61. PubMed ID: 17255466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetic study of percutaneous absorption of salicylic acid from baths with salicylate methyl ester and salicylic acid].
    Pratzel HG; Schubert E; Muhanna N
    Z Rheumatol; 1990; 49(4):185-91. PubMed ID: 2238859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depth-dependent stratum corneum permeability in human skin in vitro.
    Cadavona JJ; Zhu H; Hui X; Jung EC; Maibach HI
    J Appl Toxicol; 2016 Sep; 36(9):1207-13. PubMed ID: 26843137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous infusion of physostigmine in patients with perioperative septic shock: A pharmacokinetic/pharmacodynamic study with population pharmacokinetic modeling.
    Pinder N; Zimmermann JB; Gastine S; Würthwein G; Hempel G; Bruckner T; Hoppe-Tichy T; Weigand MA; Swoboda S
    Biomed Pharmacother; 2019 Oct; 118():109318. PubMed ID: 31398669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Permeation enhancer dodecyl 6-(dimethylamino)hexanoate increases transdermal and topical delivery of adefovir: influence of pH, ion-pairing and skin species.
    Vávrová K; Lorencová K; Novotný J; Holý A; Hrabálek A
    Eur J Pharm Biopharm; 2008 Nov; 70(3):901-7. PubMed ID: 18675907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating Maximal In Vitro Skin Permeation Flux from Studies Using Non-sink Receptor Phase Conditions.
    Yousef S; Liu X; Mostafa A; Mohammed Y; Grice JE; Anissimov YG; Sakran W; Roberts MS
    Pharm Res; 2016 Sep; 33(9):2180-94. PubMed ID: 27312087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Penetration of salicylic acid and salicylate into the multilayer membrane system and into the human horny layer.
    Neubert R; Partyka D; Wohlrab W; Dettlaff B; Fürst W; Taube KM
    Dermatol Monatsschr; 1990; 176(11):711-6. PubMed ID: 2083613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ion pairing with alkylamines on the in-vitro dermal penetration and local tissue disposition of salicylates.
    Megwa SA; Cross SE; Whitehouse MW; Benson HA; Roberts MS
    J Pharm Pharmacol; 2000 Aug; 52(8):929-40. PubMed ID: 11007063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of equine skin preparation on transdermal drug penetration in vitro.
    Mills PC; Cross SE
    Can J Vet Res; 2006 Oct; 70(4):317-20. PubMed ID: 17042388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sonophoresis. I. The use of high-frequency ultrasound to enhance transdermal drug delivery.
    Bommannan D; Okuyama H; Stauffer P; Guy RH
    Pharm Res; 1992 Apr; 9(4):559-64. PubMed ID: 1495903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of the effect of lipophilicity on the in vitro permeability and tissue reservoir characteristics of topically applied solutes in human skin layers.
    Cross SE; Magnusson BM; Winckle G; Anissimov Y; Roberts MS
    J Invest Dermatol; 2003 May; 120(5):759-64. PubMed ID: 12713577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Model representation of salicylate pharmacokinetics using unbound plasma salicylate concentrations and metabolite urinary excretion rates following a single oral dose.
    Shen J; Wanwimolruk S; Purves RD; McQueen EG; Roberts MS
    J Pharmacokinet Biopharm; 1991 Oct; 19(5):575-95. PubMed ID: 1783992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of ionization on the percutaneous absorption of drugs: partitioning of nicotine into organic liquids and hydrated stratum corneum.
    Oakley DM; Swarbrick J
    J Pharm Sci; 1987 Dec; 76(12):866-71. PubMed ID: 3440928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro release and intestinal absorption of physostigmine salicylate from submicron emulsions.
    Rubinstein A; Pathak YV; Kleinstern J; Reches A; Benita S
    J Pharm Sci; 1991 Jul; 80(7):643-7. PubMed ID: 1941560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.